{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:47:21Z","timestamp":1758044841369,"version":"3.44.0"},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"abstract":"<jats:p>Breast cancer is the most frequent neoplasm and has the highest mortality rate among women. In the Afro-descendant population, these tumors may appear earlier and assume a more aggressive behavior. This study aimed to assess the epidemiological and clinical behavior of breast cancer in a predominantly Afro-descendant population, identify risk and prognostic factors, and compare them with already available data. Clinical and sociodemographic data were obtained from medical records and interviews with the patients involved. The variables ethnicity, age, number of children, monthly income, and education were used to describe the epidemiological profile and the results of clinical evaluation and pathological anatomy study. The immunohistochemical analysis was used to correlate the clinical characteristics of the tumors and prognosis. Afro-descendant women represented 77% of the population and the mean age at diagnosis was 54.4 years. Approximately 75% had up to 2 children, 20.5% had low income, and 37.3% had a low level of education. Infiltrating ductal carcinoma was diagnosed in 91% of patients, 70.2% had a moderate degree of differentiation, luminal subtype A was the most prevalent (39%), and a higher than global average percentage had a triple negative profile (22.9%). Early stages were identified in 53.4% of patients and only 4.8% were diagnosed with metastatic disease. The recurrence rate was 11.6%, and the mortality rate was 6.8%. The present study showed that unfavorable sociodemographic and clinical aspects, such as the high prevalence of triple-negative tumors, were not associated with a worse prognosis.<\/jats:p>","DOI":"10.1590\/1414-431x2025e14749","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T15:00:58Z","timestamp":1757689258000},"source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological and clinical factors of breast cancer in a population of mostly Afro-descendant women"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7343-3331","authenticated-orcid":false,"given":"J.C.B.","family":"Neiva","sequence":"first","affiliation":[{"name":"Universidade Federal do Rec\u00f4ncavo da Bahia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1127-3867","authenticated-orcid":false,"given":"M.D.B.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rec\u00f4ncavo da Bahia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-7102","authenticated-orcid":false,"given":"M.B.P.","family":"Toralles","sequence":"additional","affiliation":[{"name":"Instituto de Ci\u00eancias da Sa\u00fade, Universidade Federal da Bahia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-406X","authenticated-orcid":false,"given":"R.S.","family":"Andrade","sequence":"additional","affiliation":[{"name":"Hospital Luiz Arg\u00f4lo, Santa Casa de Miseric\u00f3rdia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3463-6188","authenticated-orcid":false,"given":"K.J.","family":"Erfani","sequence":"additional","affiliation":[{"name":"Georgia State University,  USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4530-6589","authenticated-orcid":false,"given":"M.E.F.","family":"Maia","sequence":"additional","affiliation":[{"name":"Centro Universit\u00e1rio de Excel\u00eancia Unex,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-0097","authenticated-orcid":false,"given":"J.M.","family":"Santana","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rec\u00f4ncavo da Bahia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-0354","authenticated-orcid":false,"given":"I.M.M.","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rec\u00f4ncavo da Bahia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-1991","authenticated-orcid":false,"given":"J.B.L.","family":"Reis","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rec\u00f4ncavo da Bahia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-9663","authenticated-orcid":false,"given":"S.O.T.","family":"Klein","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rec\u00f4ncavo da Bahia,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"year":"2021","key":"ref1"},{"issue":"23","key":"ref2","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1001\/jama.2013.6447","article-title":"Incidence rate of breast cancer in young women","volume":"309","author":"Goldstein MR","year":"2013","journal-title":"JAMA"},{"issue":"15","key":"ref3","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.ejca.2008.08.015","article-title":"\u2018Breast awareness' and \u2018breast self-examination' are not the same. What do these terms mean? Why are they confused? What can we do?","volume":"44","author":"Thornton H","year":"2008","journal-title":"Eur J Cancer"},{"issue":"Suppl 2","key":"ref4","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","article-title":"Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer","volume":"9","author":"Anders CK","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/1471-2407-11-383","article-title":"Younger age as a prognostic indicator in breast cancer: a cohort study","volume":"11","author":"Kheirelseid EHA","year":"2011","journal-title":"BMC Cancer"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","article-title":"Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA","volume":"113","author":"Lund MJ","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/bcr2242","article-title":"Triple-negative breast cancers are increased in black women regardless of age or body mass index","volume":"11","author":"Stead LA","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"6797","key":"ref8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou CM","year":"2000","journal-title":"Nature"},{"issue":"15","key":"ref9","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.2011.38.2010","article-title":"Dissecting the heterogeneity of triple-negative breast cancer","volume":"30","author":"Metzger-Filho O","year":"2012","journal-title":"J Clin Oncol"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini G","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10549-019-05353-2","article-title":"Quantifying the relationship between age at diagnosis and breast cancer-specific mortality","volume":"177","author":"Johnson HM","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1055-9965.EPI-15-0535","article-title":"International variation in female breast cancer incidence and mortality rates","volume":"24","author":"DeSantis CE","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"ref13","first-page":"409","article-title":"Breast cancer statistics, 2011","volume":"61","author":"DeSantis C","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1524-4741.2009.00822.x","article-title":"Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004","volume":"15","author":"Parise CA","year":"2009","journal-title":"Breast J"},{"journal-title":"Confira as recomenda\u00e7\u00f5es do Minist\u00e9rio da Sa\u00fade para o rastreamento do c\u00e2ncer de mama","article-title":"Not\u00edcias","year":"2019","key":"ref15"},{"issue":"Suppl 6","key":"ref16","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: epidemiological considerations and recommendations","volume":"23","author":"Boyle P","year":"2012","journal-title":"Ann Oncol"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"dju237","DOI":"10.1093\/jnci\/dju237","article-title":"Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium","volume":"106","author":"Palmer JR","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"3S1","key":"ref18","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.amepre.2017.04.024","article-title":"Breastfeeding and breast cancer risk reduction: implications for black mothers","volume":"53","author":"Anstey EH","year":"2017","journal-title":"Am J Prev Med"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/annonc\/mdv379","article-title":"Breastfeeding and breast cancer risk by receptor status - a systematic review and meta-analysis","volume":"26","author":"Islami F","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","article-title":"Epidemiology of triple-negative breast cancer: a review","volume":"27","author":"Howard FM","year":"2021","journal-title":"Cancer J"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PPO.0000000000000494","article-title":"Triple-negative breast cancer: breast tumors with an identity crisis","volume":"27","author":"Nunnery SE","year":"2021","journal-title":"Cancer J"},{"issue":"7","key":"ref22","first-page":"8500","article-title":"Clinicopathological classification and traditional prognostic indicators of breast cancer","volume":"8","author":"Li J","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry","volume":"109","author":"Bauer KR","year":"2007","journal-title":"Cancer"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke C","year":"2008","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"ref25","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","article-title":"Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer","volume":"9","author":"Anders CK","year":"2009","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/PPO.0000000000000496","article-title":"Local treatment of triple-negative breast cancer","volume":"27","author":"Machiels M","year":"2021","journal-title":"Cancer J"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/PPO.0000000000000498","article-title":"Adjuvant and neoadjuvant treatment of triple-negative breast cancer with chemotherapy","volume":"27","author":"Marra A","year":"2021","journal-title":"Cancer J"},{"issue":"13","key":"ref28","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde LA","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2011.07.007","article-title":"Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multcenter trial","volume":"100","author":"Wang J","year":"2011","journal-title":"Radiother Oncol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.prro.2016.08.009","article-title":"Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update","volume":"6","author":"Recht A","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.critrevonc.2018.09.004","article-title":"Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies","volume":"131","author":"He MY","year":"2018","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2025000100664&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T15:01:04Z","timestamp":1757689264000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2025000100664&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"alternative-id":["S0100-879X2025000100664"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2025e14749","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"type":"electronic","value":"1414-431X"},{"type":"print","value":"0100-879X"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e14749"}}